Showing 39,581 - 39,600 results of 109,697 for search '(( a point decrease ) OR ( 5 ((wt decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 2.10s Refine Results
  1. 39581

    The Hepatitis B Virus Genotype Affects the Persistence of Viral Replication in Immunodeficient NOG Mice by Yoshinobu Yokoyama (836840)

    Published 2015
    “…Serum levels of HBV DNA, HBsAg and HBeAg in mice transfected with pHBA1.2 were maintained over 5 months. In contrast, those in mice with pHBC1.2 gradually decreased over time and reached undetectable levels within 3 months after transfection. …”
  2. 39582

    The 30 most commonly mutated genes from selected variants in EBV+ DLBCL identified by whole-exome sequencing. by Fang Liu (13271)

    Published 2018
    “…<p>Based on the total number of all mutation loci within one somatic mutated gene in a detected region (exonic region, intronic region, intergenic region, UTR, and other regions), the top 5 most frequently mutated genes were <i>MUC16</i>, <i>PRSS3</i>, <i>MUC19</i>, <i>MUC3A</i>, and <i>RLIM</i> in decreasing order.…”
  3. 39583

    miR-126-3p reduces VEGF secretion and endothelial tube formation. by Yin Xiong (342546)

    Published 2015
    “…<p><b>(A)</b> miR-126-3p overexpression significantly reduced secreted VEGF levels in TPC-1 and FTC-133 cell lines but not XTC-1 cells. * p < 0.5. …”
  4. 39584

    Table_1_A novel form of transcutaneous electrical nerve stimulation for the reduction of dysesthesias caused by spinal nerve dysfunction: A case series.docx by Yuki Nishi (7486787)

    Published 2022
    “…Background<p>Current therapeutic interventions for dysesthesias caused by spinal cord dysfunctions are ineffective. We propose a novel intervention using transcutaneous electrical nerve stimulation (TENS) for dysesthesias, and we present an in-depth case series.…”
  5. 39585

    Table_2_A novel form of transcutaneous electrical nerve stimulation for the reduction of dysesthesias caused by spinal nerve dysfunction: A case series.docx by Yuki Nishi (7486787)

    Published 2022
    “…Background<p>Current therapeutic interventions for dysesthesias caused by spinal cord dysfunctions are ineffective. We propose a novel intervention using transcutaneous electrical nerve stimulation (TENS) for dysesthesias, and we present an in-depth case series.…”
  6. 39586

    Table_3_A novel form of transcutaneous electrical nerve stimulation for the reduction of dysesthesias caused by spinal nerve dysfunction: A case series.docx by Yuki Nishi (7486787)

    Published 2022
    “…Background<p>Current therapeutic interventions for dysesthesias caused by spinal cord dysfunctions are ineffective. We propose a novel intervention using transcutaneous electrical nerve stimulation (TENS) for dysesthesias, and we present an in-depth case series.…”
  7. 39587

    Model for distinct G-protein modulation of <i>I</i><sub><i>Ba</i></sub> and <i>I</i><sub><i>Ca</i></sub> mediated by Ca<sub>v</sub>2.2. by Jessica R. Thomas (20691419)

    Published 2025
    “…<p>(A, B) Ca<sub>v</sub>2.2 channels are potentiated by PIP2 binding and inhibited by Gβγ binding to the channel. …”
  8. 39588

    A Simple Modified Technique of Pleuropericardial Window: Towards 0% Recurrence by Hanan M. Hemead (14224684)

    Published 2022
    “…The latter has proved to have lower incidence of recurrence; however, the technique has been continuously refined to improve the recurrence-free survival and decrease postoperative morbidity. We herein present a novel simple modification to minimize recurrence by anchoring the free edges of pericardial fenestration overlying the superior vena cava and right atrium to the chest wall. …”
  9. 39589

    A Simple Modified Technique of Pleuropericardial Window: Towards 0% Recurrence by Hanan M. Hemead (14224684)

    Published 2023
    “…The latter has proved to have lower incidence of recurrence; however, the technique has been continuously refined to improve the recurrence-free survival and decrease postoperative morbidity. We herein present a novel simple modification to minimize recurrence by anchoring the free edges of pericardial fenestration overlying the superior vena cava and right atrium to the chest wall. …”
  10. 39590

    NINL and DZANK1 associate specifically with complementary subunits of the cytoplasmic dynein 1 motor complex. by Margo Dona (816015)

    Published 2015
    “…MO-injection of sub-effective concentrations of <i>ninl</i> (0.5 ng/nl) (e-e”) or <i>dync1h1</i> (1 ng/nl) (f-f”) generates larvae with a normal phenotype and normal OS length, compared to wildtype larvae (b-b”) and control MO-injected larvae (c-c”). …”
  11. 39591
  12. 39592

    Table_1_Proteomic Analysis on Anti-Proliferative and Apoptosis Effects of Curcumin Analog, 1,5-bis(4-Hydroxy-3-Methyoxyphenyl)-1,4-Pentadiene-3-One-Treated Human Glioblastoma and N... by Yee Qian Lee (10727655)

    Published 2021
    “…Increased caspase-3 activity and decreased bcl-2 concentration upon treatment indicate that MS13 induces apoptosis in these cells in a dose- and time-dependent manner. …”
  13. 39593

    Transgenic pmes-<i>Bmp4</i> reactivates Smad1/5/8 signaling in the dermal mesenchyme in <i>Gpr177<sup>K14</sup></i>/Tg-pmes-<i>Bmp4</i>. by Xiao-Jing Zhu (645748)

    Published 2014
    “…P-Smad1/5/8 activity (white arrowheads) is preferentially decreased in dermis of limb skin in <i>Gpr177<sup>K14</sup></i> mice and increased in dermis of <i>Gpr177<sup>K14</sup></i>/Tg-pmes-<i>Bmp4</i> mice (green arrowheads) (A–C). …”
  14. 39594

    Discovery of Potent, Selective, and Brain-Penetrant 1<i>H</i>‑Pyrazol-5-yl‑1<i>H</i>‑pyrrolo[2,3‑<i>b</i>]pyridines as Anaplastic Lymphoma Kinase (ALK) Inhibitors by Makoto Fushimi (1714441)

    Published 2019
    “…Scaffold hopping and lead optimization of <i>N</i>-(2,4-difluorobenzyl)-3-(1<i>H</i>-pyrazol-5-yl)­imidazo­[1,2-<i>b</i>]­pyridazin-6-amine <b>1</b> guided by a cocrystal structure of compound <b>1</b> bound to ALK resulted in the identification of (6-(1-(5-fluoropyridin-2-yl)­ethoxy)-1-(5-methyl-1<i>H</i>-pyrazol-3-yl)-1<i>H</i>-pyrrolo­[2,3-<i>b</i>]­pyridin-3-yl)­((2<i>S</i>)-2-methylmorpholin-4-yl)­methanone <b>13</b> as a highly potent, selective, and brain-penetrable compound. …”
  15. 39595

    Table 1_Case report: A severe case of zoledronate-associated diffuse orbital inflammation and uveitis in a patient with metastatic breast cancer.docx by Pushpinder Kanda (5125214)

    Published 2024
    “…We report a case of simultaneous anterior uveitis and orbital inflammation associated with zoledronate infusion in a patient with metastatic breast cancer. …”
  16. 39596
  17. 39597
  18. 39598
  19. 39599

    The effect of IL-17A on IκBζ - RGS4 signaling. by Hirotada Akiho (559455)

    Published 2014
    “…(<b>F</b>) The effect of IL-17A, IL-1β, or IL-4 on RGS 4 activity was assessed with or without SN50, a p65 translocation inhibitor, or IκBζ siRNA (n = 4∼5). …”
  20. 39600